Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Vivos Second Quarter 2024 Earnings Conference Call.
Vivos Therapeutics Inc. (VVOS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.53 | 14,000 | Officer, Director | 86,521 | 2023-06-20 | Filing | |
| $0.53 | 5,000 | Officer, Director | 72,521 | 2023-06-16 | Filing | |
| $0.54 | 10,000 | Officer, Director | 67,521 | 2023-06-16 | Filing | |
| $0.50 | 21 | Officer, Director | 57,521 | 2023-06-15 | Filing | |
| $0.49 | 10,000 | Officer, Director | 57,500 | 2023-06-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 128,789 | $1,602,135 | 0.24% | |
| 2. | 66,300 | $824,772 | 0% | |
| 3. | 10,579 | $131,603 | 0% | |
| 4. | 1,718 | $21,372 | 0% | |
| 5. | 547 | $6,805 | 0% |
News See All
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Vivos Therapeutics First Quarter 2024 Earnings Conference Call. At this time, participants are in a listen-only mode.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2023 Earnings Call Transcript
Vivos Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.05 EPS, expectations were $-1.9.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q1 2023 Earnings Call Transcript
Operator: Good day, everyone. And welcome to the Vivos Therapeutics First Quarter 2023 Earnings Conference Call. At this time, participants are in a listen-only mode.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Q4 2022 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Vivos Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time participants are in a listen-only mode.
Is Vivos Therapeutics, Inc. (VVOS) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...
Billionaire Hedge Funds
